Protein Expression Systems Market Size Was Valued at USD 3.40 Billion in 2023, and is Projected to Reach USD 8.18 Billion by 2032, Growing at a CAGR of 10.24% From 2024-2032.

Proton Pump Inhibitors Market Size Was Valued at USD 3.6 Billion in 2023, and is Projected to Reach USD 5.8 Billion by 2032, Growing at a CAGR of 5.5% From 2024-2032.

The rapid infuser market refers to the global community comprised of companies that design, produce and sell devices used to infuse the fluids, for instance blood, saline or medication, into the circulatory system of the patient in a critical or emergency context. Importance of these devices is felt most in areas where patients are likely to have compromised circulatory status and may need fluids replacement urgently, especially in the traumatology, surgery, and ICU. The rapid infusers are meant for high speeds and large volumes of fluids and are used to increase blood volume, stabilize the vital signs and avoiding shock, dehydration or hypothermia. Some of them include; flow rate management which is accurate; continuous monitoring; and in some models, the possibility to warm the fluids before infusion to counter the consequences of cold blood or saline. Key drivers for growth include growing cases of trauma and surgical operations, rising diseases related to the state of health, and improvements of clinical technology in the administration of the fluids. There is increased worrying of emergency care services especially in the rural and urban setting, as well as the aging population that needs intensive emergency medical care, and therefore the market for the rapid infuser will grow considerably.

The recombinant protein market is the trade of proteins that are produced through biotechnology by incorporation of genes responsible for proteins formation, and their marketing after synthesizing them in other organisms. These proteins are used in drugs and medicines, in research analysis of drugs, in diagnostic tests and assays, and in other industrial applications such as food production and bio-energy production. New biologic drugs, development of biotechnology and higher research and development investments have made the market grow at a fast pace in the recent years and the market is expected to grow at a much faster pace in the future, with a special focus on increasing production capacity and reducing costs.